Overview of PCR-SSOPs with significant differences between EBV+ and EBV− cHL population
| SSOP . | Specificity of probe* . | AA positions (IMGT) . | Potential contact position† . | EBV+, % . | EBV−, % . | P . | OR . |
|---|---|---|---|---|---|---|---|
| c279 | A*02 | 9-12,23-25 | Peptide (9,24) | 23.0 | 50.0 | .00043‡ | 0.32 |
| c348 | A*02,A68 | 141-142, 144-146 | Peptide (146), TCR (145,146) | 34.6 | 60.3 | .0006‡ | 0.37 |
| c373 | A*02,A*68 | 143-146, 150-153 | Peptide (143,152),TCR (145,146,150,151) | 34.6 | 60.3 | .0006‡ | 0.37 |
| c349 | A*02 | 94-98 | Peptide (95,97) | 26.9 | 53.0 | .00076‡ | 0.36 |
| c273 | A*02,A*31 | 69-72, 76-79 | Peptide (70,77),TCR (69,72,76,79) | 31.6 | 58.2 | .00081‡ | 0.37 |
| c339 | A*02,A*24,A*68 | 150-154 | Peptide (152),TCR (150,151,154) | 48.7 | 71.6 | .002§ | 0.41 |
| c397 | A02,A*23,A*24,A*68 | 124-128 | 51.3 | 72.8 | .0025§ | 0.41 | |
| c208 | A*02 | 60-65 | Peptide (62,63), TCR (61,62,65) | 29.5 | 53.0 | .0029§ | 0.41 |
| c241 | A*02 | 70-71, 73-74, 76 | Peptide (70,73 74), TCR (76) | 29.5 | 53.0 | .0029§ | 0.41 |
| c295 | A*01,A*23,A*24,A*26, A*30, A*32 | 70-74 | Peptide (70,73,74), TCR (72) | 80.8 | 53.9 | .00007‡ | 3.79 |
| c378 | A*01 | 156, 158, 166-168 | Peptide (156,167),TCR (158,166,167) | 56.4 | 29.9 | .00013‡ | 3.05 |
| c325 | A*01 | 150-152 | Peptide (152)TCR (150,151) | 56.4 | 30.2 | .00014‡ | 3.03 |
| c375 | A*01 | 161-163, 166-168 | Peptide (163,167),TCR (162,163,166,167) | 56.4 | 30.2 | .00014‡ | 3.03 |
| c281 | A*01 | 41-44 | 55.8 | 29.3 | .00017‡ | 3.02 | |
| c395 | A*01,A*03,A*11,A*30 | 93-98 | Peptide (95,97) | 84.6 | 61.2 | .00021‡ | 3.79 |
| c331 | A*01,A*23,A*24 | 164, 166-168 | Peptide (167), TCR (166,167) | 71.8 | 47.0 | .00034‡ | 2.96 |
| c215 | A*01,A*26,A*29 | 74-77 | Peptide (74,77), TCR (76) | 59.0 | 35.5 | .001§ | 2.58 |
| c211 | A*01,A*03,A*11,A*30,A*31,A*32 | 59-60, 62-64 | Peptide (59,62,63), TCR (62) | 87.2 | 68.0 | .0016§ | 3.36 |
| c332 | A*01,A*11,A*26 | 160-163, 165 | Peptide (163), TCR (162,163) | 66.7 | 45.9 | .002§ | 2.49 |
| SSOP . | Specificity of probe* . | AA positions (IMGT) . | Potential contact position† . | EBV+, % . | EBV−, % . | P . | OR . |
|---|---|---|---|---|---|---|---|
| c279 | A*02 | 9-12,23-25 | Peptide (9,24) | 23.0 | 50.0 | .00043‡ | 0.32 |
| c348 | A*02,A68 | 141-142, 144-146 | Peptide (146), TCR (145,146) | 34.6 | 60.3 | .0006‡ | 0.37 |
| c373 | A*02,A*68 | 143-146, 150-153 | Peptide (143,152),TCR (145,146,150,151) | 34.6 | 60.3 | .0006‡ | 0.37 |
| c349 | A*02 | 94-98 | Peptide (95,97) | 26.9 | 53.0 | .00076‡ | 0.36 |
| c273 | A*02,A*31 | 69-72, 76-79 | Peptide (70,77),TCR (69,72,76,79) | 31.6 | 58.2 | .00081‡ | 0.37 |
| c339 | A*02,A*24,A*68 | 150-154 | Peptide (152),TCR (150,151,154) | 48.7 | 71.6 | .002§ | 0.41 |
| c397 | A02,A*23,A*24,A*68 | 124-128 | 51.3 | 72.8 | .0025§ | 0.41 | |
| c208 | A*02 | 60-65 | Peptide (62,63), TCR (61,62,65) | 29.5 | 53.0 | .0029§ | 0.41 |
| c241 | A*02 | 70-71, 73-74, 76 | Peptide (70,73 74), TCR (76) | 29.5 | 53.0 | .0029§ | 0.41 |
| c295 | A*01,A*23,A*24,A*26, A*30, A*32 | 70-74 | Peptide (70,73,74), TCR (72) | 80.8 | 53.9 | .00007‡ | 3.79 |
| c378 | A*01 | 156, 158, 166-168 | Peptide (156,167),TCR (158,166,167) | 56.4 | 29.9 | .00013‡ | 3.05 |
| c325 | A*01 | 150-152 | Peptide (152)TCR (150,151) | 56.4 | 30.2 | .00014‡ | 3.03 |
| c375 | A*01 | 161-163, 166-168 | Peptide (163,167),TCR (162,163,166,167) | 56.4 | 30.2 | .00014‡ | 3.03 |
| c281 | A*01 | 41-44 | 55.8 | 29.3 | .00017‡ | 3.02 | |
| c395 | A*01,A*03,A*11,A*30 | 93-98 | Peptide (95,97) | 84.6 | 61.2 | .00021‡ | 3.79 |
| c331 | A*01,A*23,A*24 | 164, 166-168 | Peptide (167), TCR (166,167) | 71.8 | 47.0 | .00034‡ | 2.96 |
| c215 | A*01,A*26,A*29 | 74-77 | Peptide (74,77), TCR (76) | 59.0 | 35.5 | .001§ | 2.58 |
| c211 | A*01,A*03,A*11,A*30,A*31,A*32 | 59-60, 62-64 | Peptide (59,62,63), TCR (62) | 87.2 | 68.0 | .0016§ | 3.36 |
| c332 | A*01,A*11,A*26 | 160-163, 165 | Peptide (163), TCR (162,163) | 66.7 | 45.9 | .002§ | 2.49 |